{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:16:45Z","timestamp":1779189405777,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jinf.2019.11.024","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T19:11:18Z","timestamp":1579201878000},"page":"310-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans"],"prefix":"10.1016","volume":"80","author":[{"given":"Junbo","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huachen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Horby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Nikolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Cauchemez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Uyeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2019.11.024_bib0001","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1473-3099(17)30323-7","article-title":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013\u201317: an epidemiological study of laboratory-confirmed case series","volume":"17","author":"Wang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2018.02.025","article-title":"From \"A\"IV to \"Z\"IKV: attacks from emerging and re-emerging pathogens","volume":"172","author":"Gao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2019.11.024_bib0003","first-page":"24","article-title":"The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in Mainland China, 2019","author":"Yu","year":"2019","journal-title":"Euro Surveill Bull Eur Maladies Transm\u202f=\u202fEur Commun Dis Bull"},{"key":"10.1016\/j.jinf.2019.11.024_bib0004","first-page":"151","article-title":"Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness","volume":"94","year":"2019","journal-title":"Wkly Epidemiol Record"},{"key":"10.1016\/j.jinf.2019.11.024_bib0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.15585\/mmwr.mm6635a2","article-title":"Update: increase in human infections with novel Asian lineage avian influenza A(H7N9) viruses during the fifth epidemic \u2013 China, October 1, 2016-August 7, 2017","volume":"66","author":"Kile","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jinf.2019.11.024_bib0006","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1128\/JVI.03173-15","article-title":"Two outbreak sources of influenza a (H7N9) viruses have been established in china","volume":"90","author":"Wang","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0007","first-page":"129","article-title":"Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jinf.2019.11.024_bib0008","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/cr.2017.129","article-title":"H7N9 virulent mutants detected in chickens in China pose an increased threat to humans","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"10.1016\/j.jinf.2019.11.024_bib0009","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2019.01.005","article-title":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in wave five: clinical and virological findings","volume":"78","author":"Yang","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2019.11.024_bib0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.chom.2018.08.006","article-title":"Rapid evolution of H7N9 highly pathogenic viruses that emerged in China in 2017","volume":"24","author":"Shi","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jinf.2019.11.024_bib0011","unstructured":"Centers for Disease Control and Prevention. Summary of influenza risk assessment tool (IRAT) results. Available at:https:\/\/www.cdc.gov\/flu\/pandemic-resources\/monitoring\/irat-virus-summaries.htm. Accessed 1 July 2019."},{"key":"10.1016\/j.jinf.2019.11.024_bib0012","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/cid\/cix930","article-title":"Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A(H7N9) virus","volume":"66","author":"Zheng","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jinf.2019.11.024_bib0013","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(13)61125-3","article-title":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance","volume":"381","author":"Hu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2019.11.024_bib0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2019.11.024_bib0015","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study","volume":"5","author":"Beigel","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jinf.2019.11.024_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2015.10.009","article-title":"Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma","volume":"41","author":"Wu","year":"2015","journal-title":"Int J Infect Dis IJID: Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0017","doi-asserted-by":"crossref","first-page":"e2985","DOI":"10.1371\/journal.pone.0002985","article-title":"Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China","volume":"3","author":"Yu","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.11.024_bib0018","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)60493-6","article-title":"Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China","volume":"371","author":"Wang","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2019.11.024_bib0019","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2213-2600(17)30266-7","article-title":"Potential and challenges of serotherapy for severe influenza","volume":"5","author":"Lee","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jinf.2019.11.024_bib0020","doi-asserted-by":"crossref","DOI":"10.3201\/eid2404.171995","article-title":"Influenza A(H7N9) virus antibody responses in survivors 1 year after infection, China, 2017","volume":"24","author":"Ma","year":"2018","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0021","article-title":"Characterization of antibody and memory T-cell response in H7N9 survivors: a cross-sectional analysis","author":"Ma","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2019.11.024_bib0022","unstructured":"Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morb Mortal Wkly Rep Recommendations and Reports 2009; 58:1\u201352."},{"key":"10.1016\/j.jinf.2019.11.024_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01024-18","article-title":"Prolonged evolution of virus-specific memory T cell immunity post severe avian influenza A (H7N9) virus infection","author":"Zhao","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0024","first-page":"633","article-title":"Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jinf.2019.11.024_bib0025","first-page":"457","article-title":"Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jinf.2019.11.024_bib0026","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3201\/eid2410.171063","article-title":"Molecular evolution, diversity, and adaptation of influenza A(H7N9) viruses in China","volume":"24","author":"Lu","year":"2018","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0027","unstructured":"World Health Organization. WHO manual on animal influenza diagnosis and surveillance. 2002; Available at:http:\/\/www.who.int\/csr\/resources\/publications\/influenza\/whocdscsrncs20025rev.pdf. Accessed 1 July 2019."},{"key":"10.1016\/j.jinf.2019.11.024_bib0028","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0029","doi-asserted-by":"crossref","first-page":"e95612","DOI":"10.1371\/journal.pone.0095612","article-title":"A combination of serological assays to detect human antibodies to the avian influenza A H7N9 virus","volume":"9","author":"Dong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.11.024_bib0030","doi-asserted-by":"crossref","first-page":"e10864","DOI":"10.1371\/journal.pone.0010864","article-title":"Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus","volume":"5","author":"Buchy","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.11.024_bib0031","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3201\/eid2002.131094","article-title":"Human antibody responses to avian influenza A(H7N9) virus, 2013","volume":"20","author":"Guo","year":"2014","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0032","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1128\/CVI.00443-15","article-title":"Suboptimal humoral immune response against influenza A(H7N9) virus is related to its internal genes","volume":"22","author":"Lee","year":"2015","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.jinf.2019.11.024_bib0033","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/infdis\/jit430","article-title":"Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study","volume":"209","author":"Yang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0034","first-page":"20657","article-title":"Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013","volume":"18","author":"Zhang","year":"2013","journal-title":"Euro Surveill Bull Eur Mal Transm\u202f=\u202fEur Commun Dis Bull"},{"key":"10.1016\/j.jinf.2019.11.024_bib0035","doi-asserted-by":"crossref","first-page":"33877","DOI":"10.1038\/srep33877","article-title":"Avian influenza A(H7N9) and (H5N1) infections among poultry and swine workers and the general population in Beijing, China, 2013\u20132015","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2019.11.024_bib0036","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3201\/eid2407.172059","article-title":"Avian influenza A virus infection among workers at live poultry markets, China, 2013\u20132016","volume":"24","author":"Ma","year":"2018","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0037","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/infdis\/jiu021","article-title":"Serological responses following influenza A(H7N9) virus infection","volume":"209","author":"Freeman","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0038","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1038\/ncomms7833","article-title":"Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+) T cells","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2019.11.024_bib0039","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41467-018-03243-7","article-title":"Clonally diverse CD38(+)HLA-DR(+)CD8(+) T cells persist during fatal H7N9 disease","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2019.11.024_bib0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jinf.2014.05.006","article-title":"Dynamic behavior of lymphocyte subgroups correlates with clinical outcomes in human H7N9 infection","volume":"69","author":"Chen","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2019.11.024_bib0041","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcv.2014.04.006","article-title":"Serologic assay for avian-origin influenza A (H7N9) virus in adults of Shanghai, Guangzhou and Yunnan, China","volume":"60","author":"Wang","year":"2014","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01202-17","article-title":"Inactivated H7 influenza virus vaccines protect mice despite inducing only low levels of neutralizing antibodies","volume":"91","author":"Kamal","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0043","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jinf.2019.11.024_bib0044","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jinf.2019.11.024_bib0046","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis: Off Publ Eur Soc Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.11.024_bib0047","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1378\/chest.12-2907","article-title":"Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection","volume":"144","author":"Hung","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2019.11.024_bib0048","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1073\/pnas.0911596107","article-title":"Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic","volume":"107","author":"Wu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jinf.2019.11.024_bib0049","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1537-2995.2011.03347.x","article-title":"Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza","volume":"52","author":"Kreil","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.jinf.2019.11.024_bib0050","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/trf.14530","article-title":"Characterization of source plasma from self-identified vaccinated or convalescent donors during the 2009 H1N1 pandemic","volume":"58","author":"Khalenkov","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.jinf.2019.11.024_bib0051","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1537-2995.2010.02651.x","article-title":"Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection","volume":"50","author":"Wong","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.jinf.2019.11.024_bib0052","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/infdis\/jiy115","article-title":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection","volume":"217","author":"Wang","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0053","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijid.2017.07.021","article-title":"Epidemiological and clinical characteristics of humans with avian influenza A (H7N9) infection in Guangdong, China, 2013-2017","volume":"65","author":"Yang","year":"2017","journal-title":"Int J Infect Dis IJID: Off Publ Int Soc Infect Dis"},{"key":"10.1016\/j.jinf.2019.11.024_bib0054","unstructured":"World Health Organization. Blood donor selection: guidelines on assessing donor suitability for blood donation. 2012; Available at:http:\/\/www.who.int\/iris\/handle\/10665\/76724. Accessed 1 July 2019."},{"key":"10.1016\/j.jinf.2019.11.024_bib0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"JAMA"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320300256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320300256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:06Z","timestamp":1759008486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320300256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0163445320300256"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.11.024","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}